Intercept Pharmaceuticals stock price target cut to 15 from 30 at B. Riley
| ICPTDelisted Stock | USD 10.31 0.16 1.53% |
Slightly above 61% of Intercept Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Intercept Pharmaceuticals suggests that many traders are alarmed regarding Intercept Pharmaceuticals' prospects. Intercept Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Intercept Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Intercept |
ICPT Complete Intercept Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Read at marketwatch.com
 |
Intercept Pharmaceuticals Fundamental Analysis
We analyze Intercept Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intercept Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intercept Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Intercept Pharmaceuticals is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Intercept Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intercept Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Intercept Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Intercept Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Intercept Pharmaceuticals Related Equities
| TERN | Terns Pharmaceuticals | 7.82 | ||||
| SRPT | Sarepta Therapeutics | 5.70 | ||||
| AKRO | Akero Therapeutics | 3.24 | ||||
| ENVB | Enveric Biosciences | 3.13 | ||||
| TGTX | TG Therapeutics | 2.16 | ||||
| VKTX | Viking Therapeutics | 2.04 | ||||
| KRYS | Krystal Biotech | 0.20 | ||||
| MDGL | Madrigal Pharmaceuticals | 1.57 | ||||
| ELEV | Elevation Oncology | 1.59 | ||||
| PTCT | PTC Therapeutics | 1.96 | ||||
| OCEA | Ocean Biomedical | 2.74 | ||||
| HEPA | Hepion Pharmaceuticals | 4.48 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Intercept Stock
If you are still planning to invest in Intercept Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intercept Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |